Annals of the New York Academy of Sciences · 2000 · 33 citations · 41 references
Life SciencesNeurologyNeuroscienceAphasiaDementiaMolecular NeuroscienceMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenetic DisordersProtein Aggregation DisordersTau PathologyMutationPyramidal SignsStraight FilamentsTau Protein AggregationTau Protein IsoformsTauopathy GeneticsTemporal Lobe AtrophyWhite Matter Pathology
We describe the clinical and pathologic phenotypes of the G389R mutation in exon 13 of the Tau gene. Progressive aphasia and memory disturbance are the initial signs and begin in the fourth or fifth decade of life, followed by apathy, indifference, hyperphagia, rigidity, pyramidal signs and dementia. Death occurs after two to five years. Magnetic resonance imaging and neuropathologic studies show frontal and temporal atrophy. Pick body-like and axonal filamentous inclusions found in the neocortex and subcortical white matter, respectively, are tau immunoreactive. Immunoblot analysis of sarkosyl-insoluble tau shows two major bands of 60 and 64 kDa that, upon dephosphorylation, resolve into four bands of three- and four-repeat isoforms. Isolated tau filaments are often straight and occasionally twisted. Recombinant mutant tau protein shows a reduced ability to promote microtubule assembly, suggesting that this may be the primary effect of the mutation. The present findings indicate that the G389R mutation in Tau can cause a dementia similar to that in Pick's disease.
41
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Mike Hutton, Corinne Lendon, Patrizia Rizzu et al. · Nature · 1998 · 3.5K citations
Life Sciences, Genetics, Neurology +14
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Parvoneh Poorkaj, Thomas D. Bird, Ellen M. Wijsman et al. · Annals of Neurology · 1998 · 1.4K citations
Life Sciences, Genetics, Neurology +13